(Q61966035)

English

A Study of Oral LGH447 in Patients With Relapsed and/or Refractory Multiple Myeloma

clinical trial

Statements

A Multi-Center, Open-Label, Dose Escalation, Phase 1 Study of Oral LGH447 in Patients With Relapsed and/or Refractory Multiple Myeloma (English)
0 references
0 references
0 references
0 references
0 references
25 April 2012
0 references
2 December 2014
0 references
79
0 references
0 references
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit